Education
About Us
Working with TipRanks
Follow Us
AbSci (ABSI)
NASDAQ:ABSI
Earnings Data
Report Date
Mar 24, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.18Last Year’s EPS
-0.25Same Quarter Last Year
Strong Buy
Based on 7 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted Absci Corporation's strategic focus on expanding its pipeline and leveraging its AI platform for drug discovery. Significant progress was made in the development of ABS-201, with promising market opportunities in AGA and endometriosis. Despite challenges with ABS-101, the company remains financially robust and anticipates new partnerships, indicating a positive outlook.Company Guidance
Pipeline Expansion and Strategic Focus
Absci Corporation is accelerating the development of ABS-201 in androgenetic alopecia (AGA) and expanding into endometriosis. The phase 1/2a trial for AGA is expected to start in December 2025, with proof of concept readouts anticipated in 2026 and 2027 for AGA and endometriosis, respectively.
Financial Position and Partnerships
Cash, cash equivalents, and marketable securities increased to $152.5 million as of 09/30/2025. Absci anticipates signing one or more drug creation partnerships, including with a large pharma company, by year-end.
Positive Interim Results for ABS-101
Interim results for ABS-101 showed extended half-life compared to first-generation competitors and a favorable safety profile with no serious adverse events.
Focus on AI-Driven Drug Discovery
Absci continues to expand its AI platform capabilities, generating interest in partnerships and enabling the creation of a unique pipeline of therapeutic programs.
ABSI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ABSI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 12, 2025 | $3.40 | $2.64 | -22.35% |
Aug 12, 2025 | $2.97 | $3.12 | +5.05% |
May 13, 2025 | $2.96 | $2.91 | -1.69% |
Mar 18, 2025 | $3.08 | $2.98 | -3.25% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does AbSci (ABSI) report earnings?
AbSci (ABSI) is schdueled to report earning on Mar 24, 2026, Before Open (Confirmed).
What is AbSci (ABSI) earnings time?
AbSci (ABSI) earnings time is at Mar 24, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ABSI EPS forecast?
ABSI EPS forecast for the fiscal quarter 2025 (Q4) is -0.18.